BioMarin Pharmaceuticals (BMRN)
BioMarin Pharmaceuticals (BMRN) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.
- BMRN last traded at $60.02 on 2026-11-20, -2.28% for the session.
- BioMarin Pharmaceuticals: market cap $11.63B, revenue $3.66B over the last four quarters.
- Over the past year BMRN returned 14.19%, with a year-to-date return of 0.99%.
BioMarin Extends Gains as Investors Weigh Growth Prospects
BioMarin rose 3.8% today, outpacing the S&P 500’s 0.8% gain and the Nasdaq 100’s 1.8% rise. The move extends a strong recent run as investors assess growth from acquired rare-disease drugs and the company’s pipeline.
Published 2026-11-19 15:00:42 UTC.